| 13-Nov-2021 | S | Standalone and Consolidated Unaudited Financial Results along with limited review reports of the Company's Statutory Auditors thereon for the 2nd Quarter and half year ended 30th September, 2021, interim dividend, stock split.
The Board of Directors of the Company at their meeting held today have decided to fix Tuesday, 11th January, 2022, as the 'Record Date' for the Members entitlement of sub-divided shares.
(As Per BSE Announcement Dated 24.12.2021)
Board have decided to fix Tuesday, 11th January, 2022, as the Record Date' for the Members entitlement of sub-divided shares. Each fully paid-up equity share of Rs.2/-each of the Company is being sub-divided into 2 fully paid-up equity shares of Re. 1/- each,pursuant to the Resolution passed by the members of the Company at the Extra-OrdinaryGeneral Meeting held on 16th December, 2021
(As Per BSE Bulletin Dated on 24.12.2021)
Trading Members of the Exchange are hereby informed that IPCA LABORATORIES LTD. has fixed the Record Date for the purpose of sub division of equity shares of the company :
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
IPCA LABORATORIES LTD.
(524494)
RECORD DATE
11.01.2022
PURPOSE
Sub Division of existing equity shares from every One equity share of Rs. 2/- each into Two equity shares of Rs. 1/- each.
SUB-DIVIDED PAID-UP VALUE
Rs.1/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
10/01/2022 DR-195/2021-2022
Note:-
i. ISIN No. INE571A01020 of Rs.2/- paid up will not be valid for transactions done on the Exchange on or after 10/01/2022.
ii. The new ISIN Number for Rs.1/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 27.12.2021)
Sub: Change in ISIN - IPCA Laboratories Limited (IPCALAB)
Members of the Exchange are hereby informed that the ISIN Code for the equity shares of the following
company shall be changed w.e.f. January 11, 2022.
Symbol
IPCALAB
Company Name
IPCA Laboratories Limited
New ISIN
INE571A01038
Remarks
Sub-Division from Rs. 2/- to Re. 1/-
The new ISIN shall be effective for all trades done on and from the Ex-date date i.e., January 10, 2022.
For and on behalf of
National Stock Exchange of India Limited
(As Per NSE Notice Dated on 05.01.2022) | 11-Jan-2022 | |
| 21-Jan-2010 | S | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 21, 2010, inter alia, has transacted the following:
The Board has also announced stock split of 5 equity shares of Rs. 2/- each for every 1 equity share of Rs. 10/- each, subject to the approval of the members of the Company in the ensuing Extraordinary General Meeting.
Ipca Laboratories Ltd has informed BSE that the members of the Company at its Extraordinary General Meeting (EGM) held on February 25, 2010, have accorded their approval for the following:
Sub-division of each of the existing Equity Share having face value of Rs. 10/- each (Rupees Ten only) into 5 (Five) equity shares of Rs. 2/- (Rupees Two only) each.
(As Per BSE Announcement Website dated on 25.02.2010)
Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 25, 2010 have decided to fix March 23, 2010, as the 'Record Date' for the Members entitlement of sub-divided shares. Each fully paid-up equity share of Rs. 10/- each of the Company is being sub-divided into 5 fully paid-up equity shares of Rs. 2/- each.
(As Per BSE Announcement Website dated on 26.02.2010)
SUB. :- Sub Division of equity shares of Ipca Laboratories Limited (Scrip Code 524494)
Trading Members of the Exchange are hereby informed that, Ipca Laboratories Limited has fixed the Record Date for the purpose of sub division of equity shares of the company.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Ipca Laboratories Limited
(524494)
RECORD DATE
23/03/2010
PURPOSE
Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into FIVE equity shares of Rs.2/- each.
SUB-DIVIDED PAID-UP VALUE
Rs.2/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
22/03/2010 DR- 240/2009- 2010
Note :-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs.2/- paid up w.e.f. 22/03/2010.
ii. ISIN No. INE571A01012 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 22/03/2010.
iii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 08.03.2010) | 23-Mar-2010 | |
| 10-Nov-2023 | D | Board has approved Interim dividend of Rs. 2/- per equity share (200%)
| 22-Nov-2023 | |
| 11-Nov-2022 | D | Board approves Dividend of Rs. 4/- (400%) per share. | 22-Nov-2022 | |
| 13-Nov-2021 | D | The Board has declared an interim dividend of Rs. 8/- per share (400%) for the financial year 2021-22. Kindly note that vide our letter dated October 20, 2021, we have already informed you that 23rd Nov ember, 2021 has been fixed as the Record Date for ascertaining the members entitlement of said interim dividend now declared which will be paid by the Company to the eligible shareholders on or before 12th December, 2021.
| 22-Nov-2021 | |
| 07-Nov-2020 | D | Standalone and Consolidated Unaudited Financial Results along with limited review report of the Company''s Statutory Auditors thereon for the 2nd Quarter and half year ended 30th September, 2020 of the financial year 2020-21
the Board has declared an interim dividend of Rs. 8/- per share (400%) for the financial year 2020-21.
| 13-Nov-2020 | |
| 12-Feb-2020 | D | We wish to inform you that the Board has declared an interim dividend of Rs. 5/- per share (250%) for the financial year 2019-20. Kindly note that vide our letter dated 4th February, 2020, we have already informed you that 20th February, 2020 has been fixed as the Record Date for ascertaining the members entitlement of said interim dividend now declared which will be paid by the Company to the eligible shareholders on or before 28th February, 2020. | 18-Feb-2020 | |
| 29-May-2019 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 29, 2019, inter alia, has recommended a dividend of Rs. 3/- per share (150%) on its equity shares of face value of Rs. 2/- each for the financial year ended March 31, 2019. | 06-Aug-2019 | |
| 29-May-2018 | D | The Board has recommended a dividend of Re. 1/- per share (50%) on its equity shares of face value of Rs. 2/- each for the financial year ended 31st March, 2018. | 02-Aug-2018 | |
| 30-May-2017 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2017, inter alia, has recommended a dividend of Re.1/- per share (50%) for the financial year ended March 31, 2017.
Kindly note that the Board has recommended a dividend of Re. 1/- per share (50%) for the financial year ended 31st March, 2017.
Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2017, inter alia, has recommended a dividend of Re.1/- per share (50%) for the financial year ended March 31, 2017. | 27-Jul-2017 | |
| 30-May-2015 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2015, inter alia, has transacted the following:
The Board has recommended a dividend of Re. 1/- per share (50%) for the financial year ended March 31, 2015 | 22-Jul-2015 | |
| 29-May-2014 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2014, inter alia, has recommended a final dividend of Rs. 2.50 per share (125%) for the financial year ended March 31, 2014. | 18-Jul-2014 | |
| 24-Oct-2013 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 24, 2013, inter alia, has declared an interim dividend of Rs. 2.50 per shares (125%) for the financial year 2013-14. | 31-Oct-2013 | |
| 30-May-2013 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has recommended a final dividend of Rs. 2.00 per share (100%) for the financial year ended March 31, 2013. | 19-Jul-2013 | |
| 25-Oct-2012 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 25, 2012, inter alia, has declared an interim dividend of 100% (Rs. 2/- per share) for the financial year 2012-13. | 01-Nov-2012 | |
| 29-May-2012 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2012, inter alia, has recommended a final dividend of Rs. 1.20 per share (60%) for the financial year ended March 31, 2012. | 20-Jul-2012 | |
| 31-Jan-2012 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 31, 2012, inter alia, has declared 2nd interim dividend of Re. 1/- per share (50%) for the financial year 2011-12. | 07-Feb-2012 | |
| 31-Oct-2011 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 31, 2011, inter alia, has declared an interim dividend of 50% (Re. 1/- per share) for the financial year 2011-12. | 03-Nov-2011 | |
| 24-May-2011 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2011, inter alia, has recommended a final dividend of Rs. 1.20/- per share (60%) for the financial year ended March 31, 2011. | 18-Jul-2011 | |
| 25-Jan-2011 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 25, 2010, inter alia, has declared 2nd interim dividend of Re. 1/ per share (50%) for the financial year 2010-11. | 01-Feb-2011 | |
| 22-Oct-2010 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 22, 2010, inter alia, has declared an interim dividend of 50% (Re. 1/- per share) for the financial year 2010-11. | 28-Oct-2010 | |
| 28-May-2010 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2010, inter alia, has recommended a Final Dividend of 50% i.e. Re. 1/- per share of Rs. 2 each for the financial year 2009-10. Together with the Interim Dividends of Rs. 9/- per share of Rs. 10 each already declared and paid, the total Dividend for the financial year amounts to 140%. | 16-Jul-2010 | |
| 21-Jan-2010 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 21, 2010, inter alia, has transacted the following:
The Board has declared 2nd interim dividend of Rs. 4/- per share (40%) for the financial year 2009-10. | 27-Jan-2010 | |
| 27-Oct-2009 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 27, 2009, inter alia, has declared an interim dividend of 50% (Rs. 5/- per share) for the financial year 2009-10. | 30-Oct-2009 | |
| 28-May-2009 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2009, inter alia, has recommended a final dividend of Rs 4/- per share for the financial year ended March 31, 2009. | 20-Jul-2009 | |
| 22-Jan-2009 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 22, 2009, inter alia, has declared 2nd interim dividend of 30% (Rs 3/- per share) for the financial year 2008-09. | 27-Jan-2009 | |
| 31-Oct-2008 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 31, 2008, inter alia, has declared an interim dividend of 40% (Rs 4/- per share) for the financial year 2008-09. | 07-Nov-2008 | |
| 29-May-2008 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2008, inter alia, has recommended a final dividend of 45% (Rs 4.50 per share) for the financial year 2007-08. Together with the interim dividend of 35% already declared and paid, the total dividend for the financial year amounts to 80% (Rs 8 per share) as against 75% (Rs 7.50 per share) in the previous year. | 14-Jul-2008 | |
| 29-Oct-2007 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 29, 2007, inter alia, has declared an interim dividend of 35% for the financial year 2007-08. | 06-Nov-2007 | |
| 25-May-2007 | D | Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2007, inter alia, has recommended a Final Dividend of Rs 4/- per share (40%) for the financial year 2006-07. Together with the Interim Dividend of Rs 3.50 per share (35%) already declared and paid, the total Dividend for the financial year amounts to Rs 7.50 per share (75%). | 10-Jul-2007 | |
| 18-Oct-2006 | D | 35% Interim Dividend | 02-Nov-2006 | |
| 18-May-2006 | D | 25% Interim Dividend | 09-Nov-2005 | |
| 01-Jun-2006 | D | 30% Dividend | 13-Sep-2005 | |
| 04-Jan-2005 | B | Members of the Exchange are hereby informed that, Ipca Laboratories Ltd. has fixed the Record Date for Bonus Issue. The transactions in the equity shares of the company should be done on an ex-bonus basis with effect from the undermentioned date.
ONE Bonus share for every ONE existing equity share held. | 31-Jan-2005 | 1:1 |
| 29-Mar-2024 | BC | Completion of second term of appointment of Mr. Anand T. Kusre as an Independent Director | 01-Apr-2024 | |
| 10-Nov-2023 | BC | Board has approved Interim dividend of Rs. 2/- per equity share (200%)
| 31-Mar-2024 | |
| 23-Feb-2024 | BC | We are enclosing herewith Postal Ballot Notice seeking approval of the Members for the special resolutions set out in the attached Postal Ballot Notice
Ipca Laboratories Limited has informed BSE a | 28-Mar-2024 | |
| 22-Jan-2024 | BC | IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Unaudited Standalone and Consolidated Fi | 14-Feb-2024 | |
| 14-Feb-2024 | BC | Appointment of Dr. (Ms.) Swati Patankar as an Independent Director | 14-Feb-2024 | |